Ex vivo expansion of hematopoietic stem and progenitor cells: Recent advances

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 2

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hematology

ISSN

2218-6204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Hematol. May 6, 2014; 3(2): 18-28
Published online May 6, 2014. doi: 10.5315/wjh.v3.i2.18

Table 2 Cell-surface makers of undifferentiated hematopoietic stem cells

Mouse	Human
CD34^low/-	CD34^low/-
Sca-1⁺	Sca-1⁺
CD90/Thy-1^+/low	CD90/Thy-1^+/low
c-Kit⁺	c-Kit⁺
CD38⁺	CD38^-
CD150⁺	CD7^-
Side population (high hoechst-efflux activity)	CD49f⁺
CD48^-	Rhodamine 123^low
CD244^-	CD133/AC133^-
Lin^-	CD45RA^-
	Lin^-

Citation: Kita K, Xiu F, Jeschke MG. Ex vivo expansion of hematopoietic stem and progenitor cells: Recent advances. World J Hematol 2014; 3(2): 18-28
URL: https://www.wjgnet.com/2218-6204/full/v3/i2/18.htm
DOI: https://dx.doi.org/10.5315/wjh.v3.i2.18

Kita K, Xiu F, Jeschke MG. Ex vivo expansion of hematopoietic stem and progenitor cells: Recent advances. World J Hematol 2014; 3(2): 18-28 [DOI: 10.5315/wjh.v3.i2.18]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.